Published in Am J Physiol on January 01, 1983
Vasopressin modulates the spontaneous electrical activity in aortic cells (line A7r5) by acting on three different types of ionic channels. Proc Natl Acad Sci U S A (1988) 1.20
Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc Natl Acad Sci U S A (1984) 1.14
Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab (2009) 1.11
Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest (1989) 1.05
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail (2012) 0.97
Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br J Pharmacol (1992) 0.95
Vasopressin-stimulated [3H]-inositol phosphate and [3H]-phosphatidylbutanol accumulation in A10 vascular smooth muscle cells. Br J Pharmacol (1992) 0.94
Significance of hyponatremia in heart failure. Heart Fail Rev (2012) 0.86
Characterization of human platelet vasopressin receptors. J Clin Invest (1985) 0.86
Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumour-cell line. Biochem J (1986) 0.82
Specific vasopressin binding to rat adrenal glomerulosa cells. Relationship to inositol lipid breakdown. Biochem J (1986) 0.80
Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles. Proc Natl Acad Sci U S A (1986) 0.79
Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. Br J Pharmacol (2001) 0.78
Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br J Pharmacol (1994) 0.78
Properties of rat anterior pituitary vasopressin receptors: relation to adenylate cyclase and the effect of corticotropin-releasing factor. Proc Natl Acad Sci U S A (1984) 0.77
Neurohypophyseal Hormones: Novel Actors of Striated Muscle Development and Homeostasis. Eur J Transl Myol (2014) 0.75
Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure. J Int Med Res (2016) 0.75
(3H)-vasopressin binding to isolated rat hepatocytes and liver membranes: regulation by GTP and relation to glycogen phosphorylase activation. J Recept Res (1980) 1.76
Porokeratosis and immunosuppression. Eur J Dermatol (1999) 1.62
Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group. Br J Psychiatry (1999) 1.62
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Specific binding of (3H) lysine-vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation. J Biol Chem (1973) 1.52
Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res (1988) 1.46
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol (1986) 1.43
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
Clinical picture: eyelid metastasis. Lancet (2001) 1.39
[Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Ann Dermatol Venereol (1999) 1.39
Does lectin-receptor complex formation produce zones of restricted mobility within the membrane? Nature (1979) 1.32
Angiotensin II and alpha-adrenergic agonists inhibit rat liver adenylate cyclase. J Biol Chem (1981) 1.31
Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest (1996) 1.28
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
The vasopressin-sensitive adenylate cyclase of the rat kidney. Effect of adrenalectomy and corticosteroids on hormonal receptor-enzyme coupling. J Biol Chem (1974) 1.25
125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand. Eur J Pharmacol (1988) 1.25
Oxytocin-sensitive adenylate cyclase in frog bladder epithelial cells. Role of calcium, nucleotides, and other factors in hormonal stimulation. J Biol Chem (1972) 1.23
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J (1995) 1.19
In Xenopus laevis, the product of a developmentally regulated mRNA is structurally and functionally homologous to a Saccharomyces cerevisiae protein involved in translation fidelity. Mol Cell Biol (1993) 1.18
[Action of noradrenaline and oxytocin in the active transport of sodium and the permeability of frog skin to water. Role of cyclic 3', 5'-AMP]. Biochim Biophys Acta (1968) 1.16
Autism and family home movies: preliminary findings. J Autism Dev Disord (1991) 1.16
Gi2-mediated activation of the MAP kinase cascade. Mol Biol Cell (1995) 1.12
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem (1986) 1.11
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions. J Biol Chem (1995) 1.11
[Analysis of the 'biologic response' relationship for the action of oxytocin and noradrenaline on the skin and bladder of the frog]. Biochim Biophys Acta (1968) 1.10
Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol (1978) 1.10
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc Natl Acad Sci U S A (2001) 1.10
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. FEBS Lett (1996) 1.09
Interactions of proteins and lipids: structure and polymorphism of protein-lipid-water phases. Nature (1969) 1.09
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
A cyclic AMP-dependent protein kinase from frog bladder epithelial cells. Biochem Biophys Res Commun (1970) 1.07
Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev (2001) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
The liver angiotensin receptor involved in the activation of glycogen phosphorylase. Biochem J (1982) 1.05
Presence of two 3'-5'-cyclic AMP phosphodiesterases in rat kidney and frog bladder epithelial cells extracts. Biochem Biophys Res Commun (1970) 1.04
Comparative morphology and paleobiology of Middle Pleistocene human remains from the Bau de l'Aubesier, Vaucluse, France. Proc Natl Acad Sci U S A (2001) 1.02
Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill (2012) 1.00
The isolated frog skin epithelium: presence of alpha and beta adrenergic receptors regulating active sodium transport and water permeability. Pflugers Arch (1972) 1.00
Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann N Y Acad Sci (1992) 0.99
Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol (1999) 0.99
Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteins. Oncogene (1993) 0.99
Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK 1 cells. Biochem J (1986) 0.98
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps. Modification of the coupling and loss of beta-adrenergic receptors. J Biol Chem (1980) 0.97
Cyclic nucleotide phosphodiesterase of Dictyostelium discoideum and its glycoprotein inhibitor: structure and expression of their genes. Dev Genet (1991) 0.97
Effects of in vivo treatment with vasopressin and analogues on renal adenylate cyclase responsiveness to vasopressin stimulation in vitro. Endocrinology (1977) 0.97
Neuroblastoma cell adenylate cyclase: direct activation by adenosine and prostaglandins. J Neurochem (1976) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Renal handling of 3'-5'-cyclic AMP in the rat. The possible role of luminal 3'-5'-cyclic AMP in the tubular reabsorption of phosphate. Pflugers Arch (1972) 0.95
Stimulus-response coupling in neurohypophysial peptide target cells. Physiol Rev (1975) 0.95
[3H]-[Thr4,Gly7]OT: a highly selective ligand for central and peripheral OT receptors. Am J Physiol (1988) 0.95
Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation. Proc Natl Acad Sci U S A (1995) 0.94
Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol (1984) 0.93
Autoradiographic localization of vasopressin and oxytocin binding sites in rat kidney. Kidney Int (1988) 0.91
Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 0.91
Neurohypophyseal hormone receptor systems in brain and periphery. Prog Brain Res (1987) 0.91
High yield photoaffinity labeling of angiotensin II receptors. Mol Pharmacol (1986) 0.91
Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Cell Immunol (1984) 0.90
A systematic study of effects of non-ionic detergens on solubilization and activity of pig kidney adenylate cyclase. Eur J Biochem (1978) 0.90
The cyclic nucleotide phosphodiesterase gene of Dictyostelium discoideum utilizes alternate promoters and splicing for the synthesis of multiple mRNAs. Mol Cell Biol (1989) 0.90
Multiple eruptive dermatofibromas in a patient with HIV infection: case report and literature review. J Cutan Pathol (2000) 0.90
Tritium labelling of 8-lysine vasopressin and its purification by affinity chromatography on sepharose bound neurophysins. FEBS Lett (1972) 0.90
Vasopressin-sensitive kidney adenylate cyclase. Structural requirements for attachment to the receptor and enzyme activation: studies with vasopressin analogues. J Biol Chem (1975) 0.89
The cyclic nucleotide phosphodiesterase of Dictyostelium discoideum: the structure of the gene and its regulation and role in development. Dev Genet (1988) 0.89
Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors. Neuroendocrinology (1995) 0.89
Interaction between the lipoamide-containing H-protein and the lipoamide dehydrogenase (L-protein) of the glycine decarboxylase multienzyme system. 1. Biochemical studies. Eur J Biochem (2000) 0.89
Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res (1993) 0.89
Vasopressin-sensitive kidney adenylate cyclase. Differential effects of monovalent ions on stimulation by fluoride, vasopressin and guanylyl 5'-imidodiphosphate. Eur J Biochem (1977) 0.89
The physical state of water at low temperatures in plasma with different water contents as studied by differential thermal analysis and differential scanning calorimetry. Cryobiology (1975) 0.89
Antidiuretic hormone-sensitive kidney adenylate cyclase. Adv Cyclic Nucleotide Res (1975) 0.88
Disseminated superficial porokeratosis in a patient with AIDS. Br J Dermatol (1994) 0.88
Pemphigus, pemphigoid, and epidermal upper-cytoplasmic antigens: changes in expression in cultured human keratinocytes. Arch Dermatol Res (1981) 0.88
Vasopressin receptors from cultured mesangial cells resemble V1a type. Am J Physiol (1987) 0.88
Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood. Immunol Lett (1984) 0.88
Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol (2011) 0.87
Adenylate cyclase from synchronized neuroblastoma cells: responsiveness to prostaglandin E1, adenosine, and dopamine during the cell cycle. Proc Natl Acad Sci U S A (1977) 0.87
Kinetic and pharmacological characterization of vasopressin membrane receptors from human kidney medulla: relation to adenylate cyclase activation. Eur J Pharmacol (1982) 0.87
Probenecide sensitive 3'-5'-cyclic AMP secretion by isoproterenol stimulated glial cells in culture. FEBS Lett (1974) 0.87
Ultrastructural immunogold labelling of human Langerhans cells enriched epidermal cell suspension. Arch Dermatol Res (1984) 0.87
[Paranoid reactions and culture]. Ann Med Psychol (Paris) (1987) 0.87
A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors. FEBS Lett (1991) 0.86
Cultured human epidermal allografts are not rejected for a long period. Arch Dermatol Res (1986) 0.86
[Users sceptical about generic drugs: an anthropological approach]. Rev Epidemiol Sante Publique (2007) 0.86
Thomsen-Friedenreich and its precursor (Tn) antigen expression in normal skin and in benign cutaneous tumours: a marker for sebaceous differentiation. Acta Derm Venereol (1998) 0.86
Vasopressin: mechanisms of receptor activation. Prog Brain Res (1983) 0.86
Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients. HIV Med (2011) 0.85
New probes for angiotensin II receptors. Synthesis, radioiodination and biological properties of biotinylated and haptenated angiotensin derivatives. Biochem J (1988) 0.85
Ontogenic development of antidiuretic hormone receptors in rat kidney: comparison of hormonal binding and adenylate cyclase activation. Mol Cell Endocrinol (1976) 0.85
Expression, lipoylation and structure determination of recombinant pea H-protein in Escherichia coli. Eur J Biochem (1996) 0.85
Growth and differentiation of human epidermal cultures used as auto- and allografts in humans. Br J Dermatol (1987) 0.85
Eosinophilic fasciitis and simvastatin. Arch Intern Med (2001) 0.85
Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains. Biochem J (1993) 0.85
Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res (2000) 0.85
Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice. Biochem J (1983) 0.84
Keratinocyte proliferation in epidermal keratinocyte disorders evaluated through PCNA/cyclin immunolabelling and AgNOR counting. Acta Derm Venereol (1993) 0.84